References
1. Knight M, Callaghan WM, Berg C et al. Trends in postpartum hemorrhage
in high resource countries: a review and recommendations from the
International Postpartum Hemorrhage Collaborative Group.BMC Pregnancy Childbirth . 2009;9:55.
2. Kramer MS, Berg C, Abenhaim H et al. Incidence, risk factors, and
temporal trends in severe postpartum hemorrhage. Am J
Obstet Gynecol . 2013;209(5):449 e1-7.
3. Say L, Chou D, Gemmill A et al. Global causes of maternal death: a
WHO systematic analysis. Lancet Glob Health .
2014;2(6):e323-33.
4. Sentilhes L, Vayssière C, Mercier FJ et al. [Postpartum hemorrhage:
Guidelines for clinical practice — Text of the Guidelines (short
text)]. J Gynecol Obstet Biol Reprod .
2014;43(10):1170-1179.
5. Ring L, Landau R. Postpartum hemorrhage: Anesthesia
management. Semin Perinatol . 2019;43(1):35-43.
6. Collis RE, Collins PW. Haemostatic management of obstetric
haemorrhage. Anaesthesia . 2015;70 Suppl 1:78-86, e27-8.
7. Ducloy-Bouthors AS, Susen S, Wong CA et al. Medical advances in the
treatment of postpartum hemorrhage. Anesth Analg .
2014;119(5):1140-7.
8. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the
past, present and future. Int J Obstet Anesth .
2013;22(2):87-91.
9. Charbit B, Mandelbrot L, Samain E et al. The decrease of fibrinogen
is an early predictor of the severity of postpartum hemorrhage.J Thromb Haemost . 2007;5(2):266-73.
10. Cortet M, Deneux-Tharaux C, Dupont C et al. Association between
fibrinogen level and severity of postpartum haemorrhage: secondary
analysis of a prospective trial. Br J Anaesth .
2012;108(6):984-9.
11. Gayat E, Resche-Rigon M, Morel O et al. Predictive factors of
advanced interventional procedures in a multicentre severe postpartum
haemorrhage study. Intensive Care Med .
2011;37(11):1816-25.
12. Collins PW, Lilley G, Bruynseels D et al. Fibrin-based clot
formation as an early and rapid biomarker for progression of postpartum
hemorrhage: a prospective study. Blood .
2014;124(11):1727-36.
13. Ahmed S, Harrity C, Johnson S et al. The efficacy of fibrinogen
concentrate compared with cryoprecipitate in major obstetric
haemorrhage–an observational study. Transfus Med .
2012;22(5):344-9.
14. Makino S, Takeda S, Kobayashi T et al. National survey of fibrinogen
concentrate usage for post-partum hemorrhage in Japan: investigated by
the Perinatology Committee, Japan Society of Obstetrics and
Gynecology. J Obstet Gynaecol Res . 2015;41(8):1155-60.
15. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction
of an algorithm for ROTEM-guided fibrinogen concentrate administration
in major obstetric haemorrhage. Anaesthesia .
2015;70(2):166-75.
16. Munoz M, Stensballe J, Ducloy-Bouthors AS et al. Patient blood
management in obstetrics: prevention and treatment of postpartum
haemorrhage. A NATA consensus statement. Blood Transfus .
2019;17(2):112-136.
17. Collins PW, Cannings-John R, Bruynseels D et al.
Viscoelastometric-guided early fibrinogen concentrate replacement during
postpartum haemorrhage: OBS2, a double-blind randomized controlled
trial. Br J Anaesth . 2017;119(3):411-421.
18. Wikkelso AJ. The role of fibrinogen and haemostatic assessment in
postpartum haemorrhage: preparations for a randomised controlled
trial. Dan Med J . 2015;62(4):B5055.
19. Ducloy-Bouthors AS, Mignon A, Huissoud C, Grouin JM, Mercier FJ.
Fibrinogen concentrate as a treatment for postpartum haemorrhage-induced
coagulopathy: A study protocol for a randomised multicentre controlled
trial. The fibrinogen in haemorrhage of DELivery (FIDEL) trial.Anaesth Crit Care Pain Med . 2016;35(4):293-8.
20. HAS, Hémorragies du post-partum immédiat , inRecommandations pour la pratique clinique . 2004, Haute Autorité
de Santé: Paris.
21. Mercier FJ, Van de Velde M. Major obstetric hemorrhage.Anesthesiol Clin . 2008;26(1):53-66, vi.
22. Kozek-Langenecker SA, Afshari A, Albaladejo P et al. Management of
severe perioperative bleeding: guidelines from the European Society of
Anaesthesiology. Eur J Anaesthesiol . 2013;30(6):270-382.
23. Toulouse E, Masseguin C, Lafont B et al. French legal approach to
clinical research. Anaesth Crit Care Pain Med .
2018;37(6):607-614.
24. Wikkelso AJ, Edwards HM, Afshari A et al. Pre-emptive treatment with
fibrinogen concentrate for postpartum haemorrhage: randomized controlled
trial. Br J Anaesth . 2015;114(4):623-33.
25. Woman Trial Collaborators. Effect of early tranexamic acid
administration on mortality, hysterectomy, and other morbidities in
women with post-partum haemorrhage (WOMAN): an international,
randomised, double-blind, placebo-controlled trial.Lancet . 2017;389(10084):2105-2116.
26. Vrachnis N, Salakos N, Iavazzo C et al. Bakri balloon tamponade for
the management of postpartum hemorrhage. Int J Gynaecol
Obstet . 2013;122(3):265-6.
27. Revert M, Rozenberg P, Cottenet J, Quantin C. Intrauterine Balloon
Tamponade for Severe Postpartum Hemorrhage. Obstet
Gynecol . 2018;131(1):143-149.
28. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen
concentrate to correct hypofibrinogenaemia rapidly during obstetric
haemorrhage. Int J Obstet Anesth . 2010;19(2):218-23.
29. Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during
major obstetric haemorrhage. Anaesthesia .
2010;65(12):1229-30.
30. Gollop ND, Chilcott J, Benton A et al. National audit of the use of
fibrinogen concentrate to correct hypofibrinogenaemia.Transfus Med . 2012;22(5):350-5.
31. Kikuchi M, Itakura A, Miki A et al. Fibrinogen concentrate
substitution therapy for obstetric hemorrhage complicated by
coagulopathy. J Obstet Gynaecol Res . 2013;39(4):770-6.
32. Sahin AS, Ozkan S. Treatment of Obstetric Hemorrhage with Fibrinogen
Concentrate. Med Sci Monit . 2019;25:1814-1821.
33. Bonnet MP, Zlotnik D, Saucedo M et al. Maternal Death Due to
Amniotic Fluid Embolism: A National Study in France. Anesth
Analg . 2018;126(1):175-182.
34. Pujolle E, Mercier FJ, Le Gouez A. Rotational thromboelastometry as
a tool in the diagnosis and management of amniotic fluid
embolism. Int J Obstet Anesth . 2019;38:146-147.